Would you give adjuvant nivolumab for IIIA melanoma?

Patients with T3aN1a( stage IIIA per AJCC7) were excluded from nivolumab adjuvant trial. Would you consider nivolumab in these patients?

1 Answer

Mednet Member

Medical Oncology · Sediman Cancer Center/University Hospitals of Cleveland Case Medical Center

Answered on

This is a very timely and excellent question. There have been recently three landmark adjuvant studies, and two recent FDA approvals that have changed our approach for patients with resected melanoma. All three studies were based on AJCC staging 7th edition and required patients to undergo complete ...

Join for free or sign in to see the full answer